Multi-Center Observational Registry: Clinical Experience With Polyfocal Bioanalogic IOL

Saturday, April 26, 2014: 1:01 PM
Room 154 (Boston Convention and Exhibition Center)
Pavel Stodulka, MD, PhD, Gemini Eye Clinic, Zlin, Czech Republic
Juraj Urminsky, MD, PhD, Bata Hospital Zlin, Zlin, Czech Republic

Narrative Responses:

Purpose
Clinical evaluation of functional results and quality of vision after bilateral implantation of a bioanalogic, polyfocal, intraocular lens WIOL-CF

Methods
The WIOL-CF bioanalogic, polyfocal, accommodative IOL were implanted bilaterally after phacoemulsification with max. 2 weeks between the first and second eye implantation. Patient with any other ophthalmic pathology were excluded. Follow-up examinations were performed two weeks and three months after surgery including uncorrected and corrected visual acuity (VA) for far, near and intermediate distances, subjective refraction, contrast sensitivity under different lighting conditions and amplitude of accommodation. The quality of vision, glare, halos, spectacle independence and the personal satisfaction of the patients was assessed with a questionnaire.

Results
43 cataract patients (86 eyes) from 12 centres have been enrolled in this non-interventional, multicentre, prospective observational registry. Mean age 63.5 years, median 65 years.

Three months after implantation mean uncorrected distance VA was 0.99 and 100% of patients are better than 0.8. Mean uncorrected near VA J3.3 and intermediate VA J1.2. Patients contrast sensitivity results was above population norm for age 50-75 years.

91% patients did not need glasses for daily activities, driving and reading and 88% expressed subjective satisfaction. Only one patient reported serious/disturbing glare and halo optical phenomena (2.3%).

Conclusion
The WIOL-CF IOL provides very good and predictable functional results after surgery and should be considered as very promising IOL for refractive and cataract surgery, correcting presbyopia.